Quantum BioPharma Ltd. is trading at $4.77 (2.2% down) today, extending a sharp multi-day slide from above $7.00 as the market continues to digest recent regulatory setbacks.
- Shares remain under significant pressure following the June 2, 2026, disclosure that the FDA placed a clinical hold on the company's Lucid-MS Investigational New Drug (IND) application.
- The ongoing weakness persists despite a first-quarter 2026 update that highlighted strengthened liquidity and reduced cash burn, as fundamental improvements have yet to offset negative sentiment surrounding the clinical hold.